Nature of Operations, Basis of Presentation and Summary of Significant Accounting Policies (Tables)

12 Months Ended

Dec. 31, 2012

Notes to Financial Statements [Abstract]

Schedule of Error Corrections and Prior Period Adjustments [Table Text Block]

		As of December 31, 2011
					Adoption
		As			of New
	Previously			Accounting				Tax		As
		Reported			Guidance		Restatement			Restated
Deferred acquisition costs and value of business acquired		$	8,191		$	(1,415)		$	-	$	6,776
Total assets			202,906			(1,415)			-		201,491
Other liabilities			4,762			(490)			138		4,410
Total liabilities			188,742			(490)			138		188,390
Retained earnings			4,126			(1,157)			(138)		2,831
Accumulated other comprehensive income (loss)			2,448			232			-		2,680
Total stockholders' equity			14,164			(925)			(138)		13,101

				For the Year Ended December 31, 2011											For the Year Ended December 31, 2010
							Adoption											Adoption
				As			of New								As			of New
			Previously			Accounting				Tax		As		Previously			Accounting				Tax		As
			Reported				Guidance		Restatement			Restated			Reported			Guidance		Restatement			Restated
Realized gain (loss)				$	(299)		$	5		$	-	$	(294)		$	(77)		$	8		$	-	$	(69)
Total revenues					10,636			5			-		10,641			10,407			8			-		10,415
Commissions and
	other expenses				3,163			101			-		3,264			3,067			107			-		3,174
Total expenses					10,037			101			-		10,138			9,173			107			-		9,280
Income (loss) from
	continuing operations
	before taxes				599			(96)			-		503			1,234			(99)			-		1,135
Federal income tax
	expense (benefit)				297			(34)			11		274			283			(35)			14		262
Income (loss) from
	continuing operations				302			(62)			(11)		229			951			(64)			(14)		873
Net income (loss)					294			(62)			(11)		221			980			(64)			(14)		902
Income (loss) from
	continuing operations
	per common share:
		Basic		$	0.99		$	(0.21)		$	(0.03)	$	0.75		$	2.53		$	(0.20)		$	(0.05)	$	2.28
		Diluted			0.95			(0.20)			(0.03)		0.72			2.45			(0.19)			(0.05)		2.21
Net income (loss) per
	common share:
		Basic			0.96			(0.21)			(0.03)		0.72			2.62			(0.20)			(0.05)		2.37
		Diluted			0.92			(0.20)			(0.03)		0.69			2.54			(0.19)			(0.05)		2.30